Rocky Mountain Chocolate Factory Addresses AB Value’s Misleading Claims in Letter to Stockholders
Letter Informs Stockholders That AB Value Has Rejected Multiple Generous Settlement Proposals to Instead Continue…
Month: September 2021
Hannan Channel Samples 1.6m @ 5.3% Copper and 83 G/T Silver and Confirms Reduced Shale Host at Tabalosos East, Peru
VANCOUVER, BC / ACCESSWIRE / September 20, 2021 / Hannan Metals Limited (“Hannan” or the…
Nepra Foods Inc. Completes Oversubscribed $7.47 Million Initial Public Offering
VANCOUVER, BC / ACCESSWIRE / September 20, 2021 / Nepra Foods Inc. (CSE:NPRA) (the “Company”…
CoTec Announces Julian Treger as CEO-Designate and Director
VANCOUVER, BC / ACCESSWIRE / Cotec Holdings Corp. (TSX-V:CTH.H) (“CoTec” or the “Company”) is pleased…
GainPool Labs Set to Revolutionize DeFi Industry through a Heuristic Methodologies.
A Cross-Chain Gateway to Launchpads and Projects Private Rounds, with Guaranteed Allocation, and a Unique…
Airtime Partecipazioni S.p.A. Admission to Trading Announcement
PARIS, FRANCE / ACCESSWIRE / September 20, 2021 / Airtime Partecipazioni S.p.A. (“Airtime” or the…
EHT’s Puerto Rico JV Receives $21M Order For 141 Additional Homes & Begins Housing Construction
Orders for 141 additional homes come from three new housing developments, representing over $21M in…
Core Assets Expands Blue Property to District Scale Land Package
VANCOUVER, BC / ACCESSWIRE / September 20, 2021 / Core Assets Corp., (“Core Assets” or…
Angle PLC Announces Parsortix Enables Gene Expression Analysis in mPCa
PARSORTIX SYSTEM ENABLES GENE EXPRESSION ANALYSIS IN METASTATIC PROSTATE CANCER PATIENTS Parsortix able to isolate…
TXA Project | A Hybrid Decentralized Exchange Offering Cross-Chain Settlement of Trades
HANOI, VIETNAM / ACCESSWIRE / September 20, 2021 / TXA App is a part of…
Tsodilo Resources Limited Announces Geotechnical Lab Results for the Preliminary Economic Assessment of Its Xaudum Iron Project in Botswana
TORONTO, ON / ACCESSWIRE / September 20, 2021 / Tsodilo Resources Limited (“Tsodilo” or the…
Evian Unveils 100% rPET Bottles Created by Loop Industries’ Innovative Recycling Technology
Committed to accelerating the development of innovative sustainable packaging solutions, evian achieves new milestone in…
Quadient Introduces iX-Series Mailing Systems and S.M.A.R.T. Essential Mail Management Software to the U.K. Market
User-focused iX-Series and S.M.A.R.T software is the most comprehensive, flexible and contemporary range of mailing…
The Media Art Festival Seasons of Media Arts is back again in the city!
17 September to 17 October, 2021 The urban Festival of Media Art Seasons of Media…
Becrypt wins Cyber/Defence Innovation Den
Government of Ontario and techUK promoting international Cyber collaboration London, UK: On 16th September, the…
Ventyx Biosciences Announces Key Appointments and Closing of $51.0 Million Series B Convertible Preferred Stock Financing Round
Drs. Sheila Gujrathi (Executive Chair), Jörn Drappa (Chief Medical Officer) and Luisa Salter-Cid (Chair of…
eureKARE announces participation of the European Innovation Council in the opening of the eureKAWARDS
eureKARE announces participation of the European Innovation Council in the opening of the eureKAWARDS Dr…
FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform
FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune…
FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform
FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune…
OSE Immunotherapeutics To Present Positive Results of Tedopi® Phase 3 Clinical Trial in Non-Small Cell Lung Cancer Patients in Secondary Resistance to Immune Checkpoint Inhibitors At the European Society for Medical Oncology (ESMO) Virtual Congress 2021
OSE Immunotherapeutics reminds the presentation on positive data of Tedopi® in non-small cell lung cancer today…